Compare HIW & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HIW | STVN |
|---|---|---|
| Founded | 1978 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Containers/Packaging |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | 1995 | 2021 |
| Metric | HIW | STVN |
|---|---|---|
| Price | $29.77 | $17.53 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $27.57 | $25.67 |
| AVG Volume (30 Days) | ★ 1.6M | 364.2K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.43% | 0.39% |
| EPS Growth | ★ 54.26 | N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $806,112,000.00 | N/A |
| Revenue This Year | $6.03 | $9.67 |
| Revenue Next Year | $3.58 | $9.99 |
| P/E Ratio | $100.76 | ★ $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.45 | $12.89 |
| 52 Week High | $32.76 | $28.00 |
| Indicator | HIW | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 65.43 | 50.76 |
| Support Level | $28.22 | $16.75 |
| Resistance Level | $30.83 | $19.41 |
| Average True Range (ATR) | 0.85 | 0.96 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 58.79 | 51.78 |
Highwoods Properties Inc is a fully integrated office REIT that owns, develops, acquires, leases, and manages office properties mainly in the best business districts of Atlanta, Charlotte, Dallas, Nashville, Orlando, Raleigh, Richmond, and Tampa. Its principal business is the operation, acquisition, and development of rental office properties, with no material inter-segment transactions. The Company evaluates performance by geographic location, and the operating results by geographic grouping are regularly reviewed by the chief operating decision maker. The core portfolio consists mainly of office properties in its key markets, with the majority of revenue derived from its Raleigh properties.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.